Trials / Completed
CompletedNCT05259670
Risk Factors for Recurrent Intussusception Successful Reduction in Pediatric Patients
Risk Factors for Recurrent Intussusception After Successful Reduction in Pediatric Patients in a Tertiary Care Hospital of Nepal: A Prospective-Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 78 (actual)
- Sponsor
- Sanjeev Kharel · Academic / Other
- Sex
- All
- Age
- 0 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
To determine risk factors associated with recurrent intussusception among pediatric patients who have undergone successful reduction at a tertiary care hospital.
Detailed description
This is the prospective observational study. In this study, 78 patients,age \<16 years with diagnosis of intussusception between June 2019 and April 2020 who had successful reduction with either hydrostatic reduction and/or operative reduction in Teaching Hospital were enrolled in the study. They were followed up to a period of 1 month for recurrence of intussusception. The recurrent cases were thus identified and various variables were compared between recurrent and non-recurrent cases by univariable and multivariable analysis. This prospective observational study was approved by the ethics committees of Institutional review board of Tribhuvan University, Institute of Medicine. A standard structured questionnaire was filled by interviewing the patient (if possible) and family members/relatives after taking informed written consent. The questionnaire documented the patient's age, sex, weight, duration of symptoms, presenting symptoms: abdominal pain, excessive cry, vomiting, lethargy, blood in stool, fever, palpable mass, constipation, diarrhoea ,location of mass, enlarged lymph nodes(LNs), blood counts and methods of reduction. Age of 2 years, weight of 12 kg and duration of symptoms of 48 hours was used to classify patients into two groups
Conditions
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2020-04-01
- Completion
- 2020-04-01
- First posted
- 2022-02-28
- Last updated
- 2022-02-28
Locations
2 sites across 1 country: Nepal
Source: ClinicalTrials.gov record NCT05259670. Inclusion in this directory is not an endorsement.